Original Publication Date: 20 May, 2014
Publication / Source: Future Oncology
Authors: Georgios D Lianos, Alberto Mangano, Stefano Rausei & Dimitrios H Roukos
After several decades of slow progress, scientific discoveries are now changing the treatment of advanced melanoma. Over the past 3 years, the list of immunotherapeutic and targeted agents approved by regulatory agencies is rapidly growing. In this editorial, we highlight advances in science and clinical medicine, the limitations of modern therapies and the future perspectives of cancer genomics in the management of melanoma patients.